P: 317.569.4844
E: patrick.cross@bakerd.com

Pat Cross is the chair of Baker & Daniels’ health and life sciences practice group and co-chair of the firm’s Health Care Reform Task Force. Pat assists the firm’s health and life sciences clients with developing and implementing strategies to comply with various aspects of the new health care reform law. He helps clients stay on top of the latest proposals for implementing regulatory reform. He advises the firm’s life sciences, health care and technology clients on corporate matters, including mergers, acquisitions and joint ventures, and regulatory compliance strategies, including antitrust, Anti-Kickback Statute, Stark Act, Medicare/Medicaid, HIPAA and HITECH compliance. Pat combines his experience in structuring and negotiating complex corporate transactions with his knowledge of the complicated regulatory environment in which health and life sciences companies operate to provide solid, practical advice to emerging and established companies. Read Pat’s Full Bio

P: 202.312.7425
E: edougherty@bakerd.com

Ed Dougherty is B&D Consulting’s health and life sciences practice group leader. Ed consults clients on the short and long short term business impacts, opportunities and challenges presented by health care reform. He assists medical device, pharmaceutical, diagnostics and biotech companies in developing and implementing strategies to support successful commercialization of novel technologies and repositioning of mature products in the U.S. health care market. Ed has significant experience helping manufacturers overcome hurdles in the health care reimbursement environment, including evidence planning, payer interaction, coverage, coding and payment. Read Ed’s Full Bio

P: 202.312.7434
E: libby.baney@bakerd.com

Libby Baney is an Advisor with B&D Consulting. She counsels clients on a variety of health care reform (PPACA) issues and regularly interacts with the federal agencies implementing health care reform. Libby works closely with Congress, FDA, CDC, NIH, CMS and related associations on issues involving patient safety, clinical research, translational science and public health. Libby provides strategic counsel and analysis on provisions involving pharmaceutical and medical device manufacturers, the 340B drug discount program, high risk pools, and other insurance reforms under the PPACA. She also counsels clients on the new Office of Consumer Information and Insurance Oversight’s development and activities, and assists in preparing formal comments in response to Federal Register notices relating to health care reform. Read Libby’s Full Bio

P: 202.589.2856
E: jennifer.carey@bakerd.com

Jennifer Nieto Carey is a health and life sciences professional, with a particular focus on federal public health policy. She provides strategic counsel to patient advocacy organizations, medical technology companies and health care provider clients on a range of federal administrative and legislative matters. Jennifer was deeply involved in the development of the Patient Protection and Affordable Care Act (PPACA) on behalf of her consumer, information technology and provider clients and worked on their behalf to shape several provisions of the bill related to care coordination and transitions, specialty care shortages, disease prevention and wellness strategies, and comparative effectiveness research. Jennifer is now working with federal agencies and Congress to implement and improve the law so that it meets her clients’ needs. In particular, she is assisting industry and consumer groups to impact implementation of the new FDA approval pathway for biosimilars (or “follow-on biologics”) authorized under PPACA. Read Jennifer’s Full Bio

P: 317.237.1336
E: libby.cierzniak@bakerd.com

Libby Cierzniak concentrates her practice in the governmental services area, representing corporations, trade associations and public sector clients before the Indiana General Assembly and state regulatory agencies. She assists clients in drafting and securing passage of legislation and regulations addressing diverse areas such as taxation, provider reimbursement, scope of practice, professional regulation and health insurance. In the health care area, she works with hospitals, physician groups, Medicaid managed care organizations, health insurers and other stakeholders in developing and implementing effective advocacy strategies. Read Libby’s full bio

P: 317.569.4600
E: brian.fennerty@bakerd.com

Brian Fennerty concentrates his practice in the area of business planning, providing advice in connection with business formation, joint ventures and partnerships, raising capital, mergers and acquisitions and tax planning. He has extensive experience in preparing and negotiating partnership and operating agreements, merger and acquisition agreements, and representing clients in tax proceedings. With regard to health care reform, Brian’s focus is on tax issues related to the new law. Read Brian’s Full Bio

P: 260.460.1673
E: steven.jackson@bakerd.com

As the author of a book chapter on the False Claims Act, Steve Jackson is particularly interested in and attuned to the Health Care Reform implications of internal investigations, false claims and the Anti-Kickback Statute. His areas of interest include advising clients on the changing burden of proof relating to the “intent” requirement of the Anti-Kickback Statute; the expansion of potential whistleblowers caused by amendments to the False Claims Act; and self-disclosure protocols and reporting of overpayments and their implications on the Anti-Kickback Statute and the False Claims Act. Read Steve’s Full Bio

P: 317.237.1201
E: scott.kosnoff@bakerd.com

Scott Kosnoff is Managing Partner of Professional Personnel at Baker & Daniels and co-chair of the firm’s insurance and financial services practice. He advises insurers on matters before the federal government, as well as implementation challenges regarding health care reform. Read Scott’s Full Bio

P: 317.237.1331
E: michael.macLean@bakerd.com

Mike MacLean concentrates his practice in the areas of employee benefits, employment and executive compensation. He has experience with health care issues that overlap in those areas, including HIPAA privacy matters, executive benefit programs, COBRA subsidy issues, and the impact of health care reform on multiemployer plans and collective bargaining agreements. Mike regularly advises clients on all aspects of employee benefits law, including pension and welfare plan design and administration, regulatory compliance, benefits issues in corporate transactions, litigation and executive compensation. Read Mike’s Full Bio

P: 260.460.1743
E: michael.nader@bakerd.com

Mike Nader, leader of the firm’s benefits and executive compensation group, works closely with employers to develop strategies to comply with the health care reform regulations and eliminate or minimize risk when denying or reducing benefits or responding to government inquiries. He also counsels clients on wellness programs and other proactive measures to minimize health care costs to employers. Mike spent several years as the Manager of Compensation and Benefits for a large corporation, which provided him with a greater understanding of the day-to-day issues (both internal and external) facing employers and service providers. Read Mike’s Full Bio

P: 317.237.1307
E: gayle.skolnik@bakerd.com

Gayle Skolnik represents employers, fiduciaries and service providers with respect to all aspects of employee benefit law, including plan design, implementation and administration; government compliance; benefits aspects of corporate transactions; training and ERISA litigation. She is well versed in all aspects of the PPACA and regularly counsels clients on the complex issues involved affecting insured and self-insured health plans, including grandfathered plan status, mandated and prohibited plan provisions, tax credits, disclosure and reporting requirements, and many others. Gayle currently chairs Baker & Daniels’ pension committee. Read Gayle’s Full Bio

P: 317.237.1009
E: joseph.smith@bakerd.com

Joe Smith focuses his practice at Baker & Daniels in government services, labor and employment law, and certified business enterprises and supplier diversity. Joe works to change, clarify and monitor state legislation. He advises clients, drafts legislation and lobbies for laws that can improve life for businesses, families and individuals in the community and throughout the state. With regard to health care form, Joe provides clients with analysis and proactive guidance as to how the new laws will impact their business operations. In addition, he closely monitors the state’s implementation of these laws on behalf of his clients. Read Joe’s Full Bio

P: 317.569.4865
E: lee.tumminello@bakerd.com

Lee Tumminello concentrates her practice in life sciences. She advises the firm’s life sciences clients on a variety of issues, including commercial, regulatory and compliance matters related to the clinical development and marketing of pharmaceuticals, biologics and medical devices as well as general corporate and commercial matters. With regard to health care reform, Lee assists pharmaceutical and medical device companies in interpreting and preparing to implement the Physician Payment Sunshine Act, a federal requirement which requires drug and device manufacturers to make annual federal disclosures of their financial relationships with health care professionals (HCPs). Lee and her colleagues have developed policies and training to assist companies in complying with the laws of several states that contain similar disclosure requirements.  In addition, Lee counsels pharmaceutical and medical device companies in understanding how they may use data and findings from comparative effectiveness studies to assist in product research and development and possibly in promotion of their products. Read Lee’s Full Bio

P: 202.312.7463
E: vincent.ventimiglia@bakerd.com

Vince Ventimiglia is a Senior Vice President with B&D Consulting’s health and life sciences practice. He recently left the U.S. Department of Health and Human Services (HHS), where he was Assistant Secretary for Legislation for more than three years. Vince’s focus is in health and life sciences, where he offers clients extensive experience in government and the private sector. He is thoroughly familiar with health policy issues from legislative, regulatory, reimbursement and budgetary perspectives, and understands the need to advance policy solutions in bi-partisan ways involving a full range of stakeholders. Read Vince’s Full Bio

P: 202.589.2809
E: david.zook@bakerd.com

Dave Zook is an advisor to the private and public sectors on federal budgetary, legislative, and regulatory matters. Dave was deeply involved in the health care reform legislation on behalf of clients in the provider, research, payer, IT, and consumer components of the sector. He worked on over a dozen provisions in the bill spanning diverse issues such as care coordination and transitions, medical loss ratio, specialty care shortages, dental benefits, disease prevention and wellness strategies, and comparative effectiveness research. Dave is now active on these and other matters for clients across the many federal agencies charged with implementing the new law both to impact the rulemaking process and to participate in innovative demonstration and pilot initiatives. Read Dave’s Full Bio